Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
BPC-157 Angiogenesis, mucosal protection VEGFR2, FAK-paxillin signaling 14–21 days for 60–70% lesion reduction 40+ preclinical studies in gastric injury models Strongest evidence for direct tissue repair; gold standard for gastri…
Semax BDNF and NGF upregulation in prefrontal cortex; neuroprotection via PI3K/Akt pathway activation 600–3000mcg/day intranasal, divided doses Intranasal spray or drops 3–7 days for subjective effects; gene expression changes wi…
BPC-157 VEGF upregulation, collagen synthesis enhancement, inflammatory cytokine suppression 10 mcg/kg daily (subcutaneous) in animal models 28 days at 2–8°C 4–12 weeks Most studied for tendon-bone healing; angiogenic effects tra…
BPC-157 250–500mcg Daily (subcutaneous or IM) VEGF upregulation, angiogenesis, fibroblast proliferation Moderate. Rat tendon models show 70% strength increase at 14 days Small injection volume, daily commitment, requires bacterio…
BPC-157 Epithelial repair, angiogenesis VEGF upregulation, NOS stabilisation Rodent models: 60% faster healing; human case reports positive 250–500 mcg SC daily Most relevant for barrier dysfunction SIBO LL-37 Antimicrobial membr…
This table compares the primary peptides used in testosterone-related research based on mechanism, half-life, dosing frequency, and documented effects on gonadotropin pathways. CJC-1295 (with DAC) GHRH analogue. Stimulates sustai…
Before diving into protocol specifics, this table summarizes the three leading peptides studied for post-viral cognitive impairment. Their mechanisms, administration routes, and what research shows about their efficacy. Semax ACT…
BPC-157 VEGF modulation, nitric oxide pathway regulation Days 0–14 post-injury Reduces collagen III deposition by 25–40% vs controls; accelerates collagen I transition Promotes controlled angiogenesis; reduces vascular permeabili…
BPC-157 Growth hormone receptor activation in fibroblasts; upregulates FAK-paxillin pathway for cell migration and ECM remodelling Proliferative phase (days 7–21) 250–500mcg daily subcutaneous Human clinical trial data absent; do…
BPC-157 GABAergic modulation in basolateral amygdala Intraperitoneal 10 μg/kg daily ~4 hours GABA_A receptor density, freezing behavior in contextual fear conditioning Strongest signal in fear extinction protocols; requires IP ad…
Before selecting a peptide for anxiety research protocols, understanding the mechanistic, temporal, and logistical differences across compounds is essential. The following table compares the three most studied peptides in anxiety…
GHRP-2 Ghrelin receptor agonist; stimulates pulsatile GH release GH/IGF-1 axis Muscle mass, grip strength 100–300 mcg SC, 1–2x daily Strong evidence for muscle preservation; requires consistent dosing to maintain GH pulse pattern…
Selank GABA-A modulation via leucine-enkephalin pathway 15–30 minutes (intranasal) 12 weeks (no tolerance) Acute fear response, GABAergic pathway mapping Gold standard for non-sedating anxiolytic mechanism studies. Reproducible a…
DSIP Binds delta sleep-inducing factor receptors in hypothalamus None. Increases slow-wave sleep without affecting REM latency or percentage 0.5–2 mg subcutaneous before sleep Oxidises rapidly above 8°C; lyophilised form stable 2…
CJC-1295 (with DAC) GHRH analog. Extends endogenous GH half-life from 7 minutes to 6–8 days, amplifies pulse amplitude Pituitary GHRH receptors 1–2mg weekly (subcutaneous) 4–6 weeks for visceral adipose reduction measurable via i…
BPC-157 Growth hormone receptor upregulation, VEGF pathway activation 0–72 hours post-injury (acute phase) 28–30 days at 2–8°C 55–62% faster tendon-to-bone healing (University of Zagreb, 2023) Best suited for acute injury models …
Before selecting peptides for a surgical recovery study, compare their mechanisms, optimal timing, and tissue-specific applications. BPC-157 VEGF receptor activation; angiogenesis in ischemic zones 0–72 hours post-surgery Muscle,…
Topical cosmetic products containing some of these peptide families are sold under cosmetics regulation by other retailers and may make cosmetic claims only. Peptides Lab UK supplies research-use-only laboratory reference compoun…
AD research model selection is critical: different models recapitulate different pathological features with varying fidelity. 5xFAD mice develop aggressive amyloid pathology from 2 months with cognitive deficits from 4 months — u…
Epitalon Telomerase activation Cellular senescence Cellular longevity GHK-Cu Collagen synthesis Skin and tissue structural decline Dermal and systemic integrity Snap-8 Neuromuscular modulation Expression lines and wrinkles Facial…